SASSO, EMANUELE
 Distribuzione geografica
Continente #
AS - Asia 1.578
EU - Europa 1.432
NA - Nord America 1.324
SA - Sud America 152
AF - Africa 39
OC - Oceania 1
Totale 4.526
Nazione #
US - Stati Uniti d'America 1.259
SG - Singapore 605
IT - Italia 550
RU - Federazione Russa 495
VN - Vietnam 350
CN - Cina 297
BR - Brasile 121
HK - Hong Kong 98
DE - Germania 77
GB - Regno Unito 73
FR - Francia 60
NL - Olanda 58
IN - India 51
BD - Bangladesh 48
FI - Finlandia 33
JP - Giappone 33
CA - Canada 28
KR - Corea 23
MX - Messico 17
SE - Svezia 16
AR - Argentina 15
CI - Costa d'Avorio 13
ZA - Sudafrica 13
ES - Italia 11
IE - Irlanda 11
PH - Filippine 10
PL - Polonia 10
AT - Austria 8
IQ - Iraq 8
TH - Thailandia 8
LT - Lituania 7
TR - Turchia 7
UA - Ucraina 7
CR - Costa Rica 6
EC - Ecuador 6
AE - Emirati Arabi Uniti 5
BE - Belgio 5
PY - Paraguay 5
ID - Indonesia 4
JO - Giordania 4
PK - Pakistan 4
RO - Romania 4
UZ - Uzbekistan 4
CL - Cile 3
GT - Guatemala 3
MY - Malesia 3
OM - Oman 3
AL - Albania 2
BW - Botswana 2
CZ - Repubblica Ceca 2
EG - Egitto 2
ET - Etiopia 2
GE - Georgia 2
GP - Guadalupe 2
JM - Giamaica 2
LA - Repubblica Popolare Democratica del Laos 2
MA - Marocco 2
NI - Nicaragua 2
TW - Taiwan 2
AF - Afghanistan, Repubblica islamica di 1
AU - Australia 1
BB - Barbados 1
BG - Bulgaria 1
BS - Bahamas 1
CG - Congo 1
CM - Camerun 1
CO - Colombia 1
DZ - Algeria 1
HN - Honduras 1
IL - Israele 1
KG - Kirghizistan 1
KH - Cambogia 1
LY - Libia 1
PA - Panama 1
PS - Palestinian Territory 1
QA - Qatar 1
RS - Serbia 1
SA - Arabia Saudita 1
SK - Slovacchia (Repubblica Slovacca) 1
TC - Turks e Caicos 1
TN - Tunisia 1
VE - Venezuela 1
Totale 4.526
Città #
Singapore 298
Naples 237
San Jose 232
Ashburn 143
Moscow 119
Chandler 106
Hong Kong 96
Beijing 90
Ho Chi Minh City 89
Hanoi 73
Santa Clara 70
Hefei 52
Amsterdam 51
The Dalles 45
Los Angeles 44
Napoli 35
Lauterbourg 33
Tokyo 27
Munich 26
New York 25
Millbury 22
Dallas 20
Pune 16
Rome 16
Frankfurt am Main 15
San Paolo Bel Sito 15
Seoul 15
Lawrence 14
Redondo Beach 14
São Paulo 13
Buffalo 12
Chicago 12
Da Nang 12
Denver 12
Haiphong 12
Helsinki 12
Biên Hòa 11
Boston 11
Des Moines 11
Milan 11
Orem 11
Seattle 11
Council Bluffs 10
Nanjing 10
Toronto 10
Florence 9
Kochi 9
Lappeenranta 9
London 9
Brooklyn 8
Düsseldorf 8
Falkenstein 8
Houston 8
Warsaw 8
Hải Dương 7
Johannesburg 7
Marano 7
Stockholm 7
Wilmington 7
Chennai 6
Columbus 6
Formia 6
Hangzhou 6
Mexico City 6
Nuremberg 6
Ottawa 6
Princeton 6
San José 6
Tianjin 6
Turku 6
Washington 6
Atlanta 5
Belo Horizonte 5
Capaccio 5
Hyderabad 5
Montreal 5
Nha Trang 5
Phoenix 5
Poplar 5
Portsmouth 5
San Francisco 5
Amman 4
Bologna 4
Brussels 4
Ercolano 4
Jiaxing 4
Marano di Napoli 4
Memphis 4
New Delhi 4
Salerno 4
Shanghai 4
Thái Bình 4
Trentola-Ducenta 4
Acerra 3
Afragola 3
Arezzo 3
Avellino 3
Baghdad 3
Bắc Giang 3
Campinas 3
Totale 2.521
Nome #
Revealing membrane alteration in cellsoverexpressing CA IX and EGFR by Surface-Enhanced Raman Scattering 202
Generation of a novel mesothelin-targeted oncolytic herpes virus and implemented strategies for manufacturing 193
Integrating system biology and intratumor gene therapy by trans-complementing the appropriate co-stimulatory molecule as payload in oncolytic herpes virus 189
Integrity of the antiviral STING-mediated DNA sensing in tumor cells is required to sustain the immunotherapeutic efficacy of herpes simplex oncolytic virus 180
A Novel Human Neutralizing mAb Recognizes Delta, Gamma and Omicron Variants of SARS-CoV-2 and Can Be Used in Combination with Sotrovimab 178
Novel human neutralizing mAbs specific for Spike-RBD of SARS-CoV-2 172
One-Step Recovery of scFv Clones from High-Throughput Sequencing-Based Screening of Phage Display Libraries Challenged to Cells Expressing Native Claudin-1 152
Generation of a retargeted oncolytic herpes virus encoding adenosine deaminase for tumor adenosine clearance 151
Binding of Carbonic Anhydrase IX to 45S rDNA Genes Is Prevented by Exportin-1 in Hypoxic Cells 148
Isolation of Two Novel Human Anti-CTLA-4 mAbs with Intriguing Biological Properties on Tumor and NK Cells 147
Massive parallel screening of phage libraries for the generation of repertoires of human immunomodulatory monoclonal antibodies. 146
Rapid Affinity Maturation of Novel Anti-PD-L1 Antibodies by a Fast Drop of the Antigen Concentration and FACS Selection of Yeast Libraries 146
Novel human anti-Claudin 1 monoclonal antibodies inhibit HCV infection and may synergize with anti-SRB1 mAb. 144
A long non-coding SINEUP RNA boosts semi-stable production of fully human monoclonal antibodies in HEK293E cells 144
Prime and pull of Tcell responses against cancer-exogenous antigens is effective against CPI-resistant tumors 137
Systems Biology Approaches for the Improvement of Oncolytic Virus-Based Immunotherapies 136
Novel combinations of human immunomodulatory mAbs lacking cardiotoxic effects for therapy of TNBC 135
New Insights on the Role of Anti-PD-L1 and Anti-CTLA-4 mAbs on Different Lymphocytes Subpopulations in TNBC 134
High-Throughput Monoclonal Antibody Discovery from Phage Libraries: Challenging the Current Preclinical Pipeline to Keep the Pace with the Increasing mAb Demand 134
New viral vectors for infectious diseases and cancer 132
Disclosing the Interaction of Carbonic Anhydrase IX with Cullin-Associated NEDD8-Dissociated Protein 1 by Molecular Modeling and Integrated Binding Measurements 131
Retargeted and Multi-cytokine-Armed Herpes Virus Is a Potent Cancer Endovaccine for Local and Systemic Anti-tumor Treatment 131
Peptide nucleic acid-mediated circularization of target RNA as tool to inhibit translation 127
Carbonic anhydrase IX subcellular localization in normoxic and hypoxic SH-SY5Y neuroblastoma cells is assisted by its C-terminal protein interaction domain 126
Comparative Analysis of a Human Neutralizing mAb Specific for SARS-CoV-2 Spike-RBD with Cilgavimab and Tixagevimab for the Efficacy on the Omicron Variant in Neutralizing and Detection Assays 126
Replicative conditioning of Herpes simplex type 1 virus by Survivin promoter, combined to ERBB2 retargeting, improves tumour cell-restricted oncolysis 124
Targeted invalidation of SR-B1 in macrophages reduces macrophage apoptosis and accelerates atherosclerosis 120
A functional analysis of the unclassified Pro2767Ser BRCA2 variant reveals its potential pathogenicity that acts by hampering DNA binding and homology-mediated DNA repair 120
Identification of a microRNA (miR-663a) induced by ER stress and its target gene PLOD3 by a combined microRNome and proteome approach 117
The common H232 STING allele shows impaired activities in DNA sensing, susceptibility to viral infection, and in monocyte cell function, while the HAQ variant possesses wild-type properties 105
Generation of novel human anti-OX-40 mAbs endowed with different biological properties as tools for cancer therapy 80
Recombineering-based Manufacturing of Engineered Viral Vectors for Research and Therapy 67
Adenovirus Encoded Adjuvant (AdEnA) anti-CTLA-4, a novel strategy to improve Adenovirus based vaccines against infectious diseases and cancer 41
Lipid self-assembling nanoparticles as a novel platform for mRNA-based vaccination 32
We ARE boosting translation: AU-rich elements for enhanced therapeutic mRNA translation 30
FKBP5 isoforms shape immune pathways related to tumor tolerance 20
Broadly cross-reactive mRNA COVID-19 vaccine encoding trimeric RBDs and NSP12 mitigates immune imprinting 12
Publisher Correction: Revealing membrane alteration in cells overexpressing CA IX and EGFR by Surface-Enhanced Raman Scattering (Scientific Reports, (2019), 9, 1, (1832), 10.1038/s41598-018-37997-3) 6
Editorial: Crosstalk in tumor microenvironments: shaping early drug and immunotherapy strategies 4
Totale 4.619
Categoria #
all - tutte 13.659
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 13.659


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022211 3 5 11 4 9 10 31 12 24 22 39 41
2022/2023274 22 16 5 22 34 35 1 20 44 50 23 2
2023/2024287 15 26 56 29 13 45 8 20 3 29 31 12
2024/20251.241 73 35 29 24 42 96 108 80 58 136 458 102
2025/20262.432 223 140 212 220 423 111 261 114 308 192 125 103
2026/20278 8 0 0 0 0 0 0 0 0 0 0 0
Totale 4.619